StonvexLoading…
StonvexStonvexStonvexCore line items from IVDA's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $1.49M | $5.28M | $4.65M | $3.00M |
Operating Income | $-565.70K | $-3.23M | $-1.58M | $-1.37M |
Net Income | $-532.83K | $-3.20M | $-1.58M | $-564.25K |
EPS (Diluted) | $-0.06 | $-0.88 | $-0.54 | $-0.48 |
Total Assets | $7.86M | $6.43M | $5.78M | $4.39M |
Total Liabilities | $1.99M | $1.65M | $2.01M | $2.91M |
Cash & Equivalents | $5.63M | $5.16M | $3.30M | $1.59M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 11.59M | 5.88M | 4.46M | 2.91M |